康惠製藥(603139.SH):公司的複方雙花片具有清熱解毒,利咽消腫作用
格隆匯1月4日丨康惠製藥(603139.SH)在投資者互動平台表示,公司的複方雙花片具有清熱解毒,利咽消腫作用,主要用於風熱外感、風熱乳蛾。症見發熱,微惡風,頭痛,鼻塞流涕,咽紅而痛或咽喉乾燥灼痛,吞嚥則加劇,咽扁桃體紅腫,舌邊尖紅苔薄黃或舌紅苔黃,脈浮數或數;新雪片具有消炎解熱作用,主要用於各種熱性病之發熱,如扁桃腺炎、上呼吸道炎、咽炎、氣管炎、感冒所引起的高熱,以及温熱病之煩熱不解。複方雙花片及新雪片屬呼吸系統疾病用藥,在呼吸系統疾病高發的秋冬季節使用較為廣泛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.